The aim of the study was to determine HIV incidence among men who have sex with men (MSM) who repeat test for HIV at sexually transmitted infection (STI) clinics in England, and identify associated factors.
Introduction
Into the fourth decade of the HIV epidemic in the UK, men who have sex with men (MSM) remain most at risk of HIV infection and the group among whom controlling the HIV epidemic remains a public health priority [1] . In 2012, 3230 new HIV diagnoses were reported among MSM in the UK [2] . In the same year, over 34 000 MSM were living with diagnosed HIV infection and coverage of antiretroviral therapy, which is freely available, was 86%.
Most MSM are tested for and diagnosed with HIV infection in free and confidential sexually transmitted infection (STI) clinics, of which there are 215 in England. Available behavioural data show that STI clinics serve an MSM population who report a higher frequency of sexual risk behaviours, such as reporting ≥ 10 sexual partners [3] , reporting casual condomless sex or not exclusively serosorting, all in the last year [4] , than MSM who do not attend clinics.
New HIV diagnoses, however, do not necessarily reflect HIV incidence as they include long-standing and recently acquired infections and are also influenced by the volume of HIV testing performed. HIV incidence is considered the most important measure to describe the current HIV epidemic and identify subgroups at greatest risk of infection. Incidence estimates among MSM clinic attendees in England from the last decade ranged between 2% and 3% [5, 6] , while more recent estimates from the general MSM population show the incidence to be < 1% [7] [8] [9] . The behavioural data and incidence estimates highlight that MSM attending STI clinics are at higher risk, and devising a method that allows HIV incidence to be routinely measured is key to monitoring the epidemic in this population and ensuring that clinics can direct prevention services appropriately.
We employed a simple approach to estimate HIV incidence, which used data from recently established national surveillance from STI clinics in England. These data can readily provide recent incidence measures and additionally allow characteristics associated with acquisition of HIV infection to be further investigated. Here, we determined HIV incidence in an open national cohort of MSM attending STI clinics in England in 2012 and identified predictors for HIV acquisition to help identify subgroups to which HIV prevention services can be directed for the greatest impact on HIV transmission.
Methods

Data source
The national reporting system of patient-level data known as the Genitourinary Medicine Clinic Activity Dataset (GUMCAD) was set up in all STI clinics in England from 2008 and a full description is available elsewhere [10] . Briefly, all clinics provide data quarterly to Public Health England. The database contains sociodemographic (age group, ethnicity and region of residence), HIV testing and STI screening and diagnosis information on patients attending STI clinics in England. Patient identifiers are anonymized so that patients can only be longitudinally linked and followed within clinics using a unique clinic identification number generated by the local clinic computer system. Thus, identification of individuals across clinics is not possible.
In this study, two analyses were conducted using GUMCAD. The first provides an overview of the characteristics of the HIV-negative MSM population attending any of the 215 STI clinics in England in 2012 and the second estimated HIV incidence in the subset of the negative population who had at least two HIV tests within 12 months at the same clinic.
HIV-negative MSM
MSM attending any STI clinic in England in 2012 and who were not known to be HIV positive were identified in GUMCAD. These were men with no previous clinical record indicating an HIV diagnosis from the same clinic and/or with an HIV-negative test at the first visit in 2012. We also used any records available after the first attendance in 2012 to establish the HIV status of the individual if it was not clear from their clinical history or if no clinical history was available.
Sociodemographic characteristics were summarized and proportions of available clinical risk markers examined. Clinical risk markers related to the year prior to the initial attendance in 2012 (for those who previously attended in 2011) and to the initial attendance in 2012. Markers included an acute STI diagnosis and having a prior HIV test and/or sexual health screen. An acute STI diagnosis included: chlamydia, gonorrhoea, syphilis (primary, secondary and early latent), lymphogranuloma venereum (LGV), nonspecific genital infection (NSGI), chancroid, first episode of genital warts and genital herpes and donovanosis.
Repeat testers and HIV incidence
MSM who tested HIV negative at any STI clinic in 2012 and had another test more than 42 days later at the same clinic were followed from the date of their earliest HIV test for up to 1 year until they either seroconverted or until their last attendance in the 12-month period after their first test. Any HIV test within 42 days of the first test was considered to belong to the same testing episode. An episode of care lasts 42 days to allow for disparities in dates reported for HIV/STI tests, diagnoses and treatments. A seroconversion was a new HIV diagnosis occurring after the last HIV negative test.
The Kaplan-Meier method was used to calculate HIV incidence in 2012. Incidence rates were calculated for subgroups, including by previous clinic attendance history, and expressed per 100 person-years (PY) with 95% confidence intervals (CIs). In univariate analyses, associations between HIV incidence and clinical and demographic characteristics were evaluated using the log rank test. Variables with marginal associations (P < 0.1) were included in multivariable Cox regression analyses. Repeat testers who had not attended in the previous year were combined with those who did attend but were not diagnosed with an STI or did not have an HIV test. We combined them, as HIV incidence did not differ in the two groups, suggesting that their risks for HIV infection were comparable. A stepwise backward approach was used to sequentially remove variables not significant (P > 0.05) in order of the P-value magnitude. Adjusted hazard ratios (aHRs) and 95% CIs were reported for risk markers significantly associated with HIV acquisition (P < 0.05 using the likelihood ratio test).
Absolute numbers in the text have been rounded to the nearest hundred; actual numbers are presented in the tables. All statistical analyses were conducted using STATA 13.1 (StataCorp, College Station, TX, USA).
The relative contribution of each predictive factor was determined by calculating population attributable risk (PAR), which combines the adjusted HR and the prevalence of the variable among repeat testers using the formula: prevalence (HR À 1)/prevalence (HR À 1)
Results
HIV-negative MSM
In 2012, 85 500 MSM not known to be HIV positive attended any STI clinic in England (Fig. 1) . The mean age of attendees was 34 years [standard deviation (SD) 21.2 years]. Eighty per cent were of white ethnicity, over two-thirds were born in the UK and almost half were resident in London (47%). Of the other ethnic groups, 5% were of black ethnicity, with 45% of these individuals being black Caribbean, 35% black African and the remainder of other black ethnicity.
For 57% of men, this was the first recorded attendance at an STI clinic since 2008, while 25% had attended the same clinic in the year prior to their initial attendance in 2012. After the initial attendance in 2012, only 41% re-attended the same clinic within 12 months (but more than 42 days after the first attendance) [median attendances per annum 3; interquartile range (IQR) 2-4]. Of all MSM not known to be HIV positive, 14% did not test for HIV at the first attendance in 2012 or in the following 12 months, 56% tested for HIV once and the remainder tested at least twice ("repeat testers"; Fig. 1 ).
The demographic profiles of the repeat (26 200) and nonrepeat testers (59 300) differed by age (≥ 35 years: 37% vs. 40%, respectively; P < 0.001), birth in the UK (69% vs. 66%, respectively; P < 0.001) and residency in London (46% vs. 50%, respectively; P < 0.001). Eighty per cent of both groups were of white ethnicity. A third of repeat testers had also tested in the previous year compared with 17% of nonrepeat testers (P < 0.001). Forty-eight per cent of repeat testers had never attended since 2008 compared with 61% of nonrepeat testers (P < 0.001). A tenth of repeat testers were diagnosed with an acute STI in the previous year compared with 6% of nonrepeat testers (P < 0.001).
Repeat testers
The 26 200 (31%) MSM who repeat tested for HIV within 1 year and at the same clinic were included in the HIV incidence analyses. Just over a quarter were in the youngest age group (15-24 years), a further 38% were aged 25-34 years and the remaining 34% were aged ≥ 35 years.
At the first attendance in 2012, 19% were diagnosed with an acute STI. Of all repeat testers, 9300 (rounded to nearest hundred; 35%) had attended the same clinic in the year prior to their first attendance in 2012 (Fig. 1 ). Of these, 95% were tested for HIV or had an STI screen, and 26% were diagnosed with bacterial STIs, of which 20% were rectal infections. A total of 417 (4.5%) MSM had taken post-exposure prophylaxis (PEP) in the previous year. follow-up, giving an HIV incidence of 2.0 per 100 PY (95% CI 1.8-2.2) in 2012. Incidence differed by subgroup (Table 1) . Incidence was higher among MSM of black ethnicity (3.2 per 100 PY), those born abroad (2.5 per 100 PY) and those diagnosed with a bacterial STI at the initial attendance (3.2 per 100 PY). Incidence was nonsignificantly higher among MSM attending in the previous year (2.3 per 100 PY; 95% CI 1.9-2.7 per 100 PY) compared with those who did not attend in the previous year (1.8 per 100 PY; 95% CI 1.6-2.1 per 100 PY).
HIV incidence
HIV incidence was significantly higher among MSM who were diagnosed with an acute STI in the previous year (3.4 per 100 PY) and in particular among those previously diagnosed with chlamydia (4.5 per 100 PY), gonorrhoea (4.3 per 100 PY) and syphilis (7.1 per 100 PY) infections (Table 2) . Incidence did not differ by genital wart or herpes infection.
Predictors of HIV acquisition and population attributable risk
In multivariable analyses, a bacterial STI and a rectal STI at the initial attendance in 2012 were associated with increased risk of acquiring HIV in the subsequent year (aHR 1.4 and 2.1, respectively; Table 3 ). Two clinical markers from the previous year were also predictive of HIV infection: a previous syphilis or gonorrhoea infection. MSM previously diagnosed with syphilis were at more than four times greater risk of going on to acquire HIV (aHR 4.1; 95% CI 2.1-8.3). Finally, of the demographic variables, men living in London were 1.4 times more likely to acquire HIV (95% CI 1.1-1.8).
The population attributable risk for HIV infection was 2.1% (95% CI 0.7-4.8) for syphilis, whereas a previous gonorrhoea infection accounted for almost 4% of HIV CI, confidence interval; PEP, post-exposure prophylaxis. *Bacterial STI includes: chlamydia, gonorrhoea, syphilis (primary, secondary and early latent), lymphogranuloma venereum (LGV), nonspecific genital infection (NSGI), chancroid and donovanosis. † Acute STI includes all the above and first episode of genital warts and herpes.
infections among all repeat testers. The clinical markers from the previous year together accounted for 6% of all HIV infections, while those at the initial attendance accounted for another 12%. Living in London accounted for the greatest proportion (19%). Therefore, in total, the risk predictors accounted for over a third of all HIV infections occurring in the population.
Discussion
Our study uniquely used data from a large national open cohort of MSM to provide insights into the characteristics of HIV-negative MSM attending STI clinics in England. It also provides an indication of HIV risk and incidence in a subset that regularly test for HIV in the setting where HIV prevention can most suitably be delivered. Annual HIV incidence was high, at 2% among repeat testing MSM, with significantly higher incidence in groups such as MSM diagnosed with a rectal STI in the previous year (5.4%). MSM diagnosed with a rectal STI at the initial attendance in 2012 were twice as likely to acquire HIV in the following year and men with a previous syphilis infection were at more than four times increased risk. Together, the risk factors accounted for 37% of all HIV infections observed in the population. There are several limitations to this study. First, GUM-CAD can only be used to follow up individuals within clinics and not between clinics. Movement between clinics is likely to be particularly common in urban areas such as London where the availability of more clinics will impact clinic choice [12] . Recent data collected from a small number of STI clinics suggest that 9% of MSM attended another STI clinic in the previous year [13] . Thus, the number of MSM who repeat test within 1 year at the same clinic is probably an underestimate of repeat HIV testing among MSM generally and could partly explain why 14% did not have an HIV test at their first attendance. HIV incidence estimates may also be underestimated if MSM at higher risk of HIV acquisition are also more likely to attend more than one STI clinic for HIV testing. However, we cannot ascertain whether this is the case from the available data. Further, without the ability to identify individuals attending more than one clinic, the study population in 2012 may have been overestimated. Secondly, assuming that 85% of all new HIV diagnoses among MSM were made in STI clinics, there were approximately 2390 new HIV diagnoses in England reported to national HIV surveillance in 2012 compared with 2000 to GUMCAD [14] . Therefore, a small number of seroconversions may be missing from this analysis. The discrepancies between the two surveillance systems are probably attributable to the differences in the reporting pathways. Thirdly, by grouping MSM without clinical history with MSM attending in the previous year but without HIV tests or STI diagnoses, we may have misclassified some MSM who could have been diagnosed at other clinics in the previous year. However, this approach increases the similarity between this group and MSM attending in the previous year with a diagnosis, and any bias in the results would be towards an underestimation CI, confidence interval; HR, hazard ratio; NSGI, nonspecific genital infection; NS, not significant (P > 0.05); PAR, population attributable risk; PEP, post-exposure prophylaxis. *In the final model, residence was the only variable with incomplete information and those without residence information were excluded. † PAR was only calculated for risk factors significant in the multivariable analyses.
of the effect of prior history on HIV infection risk. We conducted sensitivity analyses to determine risk factors for MSM with clinical history (n = 9300) and found four of the same five risk factors. The exception was a rectal bacterial infection at the initial attendance, which was only a risk factor for all repeat testers. Additionally, the magnitudes of the effects were very similar. Fourthly, incidence estimates reported here cannot be generalized beyond our population of MSM who repeat tested at the same clinic. Finally, we did not have any behavioural information for MSM attending STI clinics as this information is not routinely collected in national surveillance. Sexual behaviours, such as condomless receptive anal intercourse (RAI) [15] , condomless RAI with HIV-serodiscordant partners [16] and high numbers of partners [16] [17] [18] , are known risk factors for HIV acquisition and would have accounted for a greater proportion of the HIV infections observed in the population than the available clinical markers. Our incidence estimate is consistent with the results of other studies among MSM clinic attendees in England from 2001 (2.5 per 100 PY; 95% CI 1.7-3.5) [6] and 2004 (3%; 95% CI 1.9-4.6%) [5] . While these two studies employed a different methodology to estimate incidence, their results suggest that incidence has remained relatively stable and high over the past 10 years among men attending STI clinics [19] . Our estimates are also comparable with those for cohorts of MSM in Portugal (2.8 per 100 PY) [20] , Spain (2.4 per 100 PY) [21] , Germany (3.3%) [22] and the USA (2.4 per 100 PY) [23] but higher than that for clinic-attending MSM in Australia (1.3 per 100 PY) [24] . Different mathematical models have been developed to estimate HIV incidence among the general MSM population. These have produced an incidence rate of 0.9% (95% CI 0.5-1.3%) in the general MSM population aged 15-44 years in England and Wales in 2007 [9] , a mean annual incidence of 0.5% between 1998 and 2010 among MSM in the UK [8] and an incidence rate of approximately 0.3% (2500 new infections) among MSM in England and Wales in 2010 [7] . These estimates indicate that the incidence in clinicattending MSM is approximately two-to seven-fold higher than in the general MSM population.
This analysis was conducted among repeat testers, a diverse population of men seeking HIV testing services for different reasons. GUMCAD does not collect information on the reason for testing; however, men may test frequently as they continue to engage in high-risk behaviours or as a reassurance mechanism. Community surveys indicated that over half of MSM were regularly tested as part of their sexual health check while 36% were tested following a risk event [25] . Furthermore, men reporting at least four tests in the last 2 years were also more likely to report ≥ 10 sexual and ≥ 10 anal intercourse partners than those reporting zero or one test, indicating a higher risk population of frequent testers. Other studies have also found some association between being a repeat tester and reporting risky sexual behaviours when compared with first-time testers [26, 27] . Our data suggest that repeat testers, while demographically similar to nonrepeat testers, may be a higher risk population. A greater proportion had been tested for HIV and been diagnosed with an acute STI in the previous year. However, we did not have behavioural data to conclusively determine if sexual behaviours differed between the two populations.
We were able to identify strata of MSM who were at high risk of HIV acquisition. Previous gonorrhoea and syphilis infections have been reported as predictors of infection [17, 28, 29] and were also shown here to increase the risk of acquiring HIV two-to four-fold. Rectal infections were also associated with HIV acquisition, similar to the results of a study in New York [30] . Rectal infections reflect the practice of risky sexual behaviours, including condomless RAI. The estimated per-act probability of acquiring HIV when engaging in condomless RAI is 138 per 10 000 exposures to an infected source; the highest probability associated with any sexual exposure [31] .
Geographical location was the only sociodemographic factor associated with increased risk, with London residents at higher risk than residents elsewhere in the UK. This finding may be explained by geographical differences in HIV prevalence and behaviours. HIV prevalence was significantly higher in London (2013: 132 per 1000 MSM aged 15-59 years) than in the rest of the UK (39 per 1000 MSM) [32] ; thus, although the proportion of MSM living in London unaware of their infection is lower than outside London, onward transmission of HIV is likely to be higher in London. Further, the proportion of undiagnosed MSM who had tested for HIV in the past year in London has significantly increased since 2000, suggesting that in recent years a greater number of infections in this population were acquired in the year following the last HIV test [4] . The proportion of MSM from community samples in London reporting condomless anal intercourse in the last year increased from 43% to 53% between 2000 and 2013 [4] . This compares to 40% among MSM in Scotland in 2008 [33] . There is also some evidence that other behaviours such as recreational drug use have also increased among core groups of MSM in London [34] .
While gonorrhoea, syphilis and rectal infections were predictive for HIV infection, their low occurrence in the population resulted in small population attributable risks and most HIV infections were not predicted by STI history. High-risk behaviours, including condomless RAI, which occur more frequently in the population than the STIs identified in this study and are strongly associated with HIV acquisition, have a high population attributable risk [11] . Therefore, capturing behavioural information would be more useful than the currently available clinical outcomes, especially for identifying high-risk MSM in clinical settings and guiding better decision making for HIV prevention [35] . A clinical audit indicated that routine collation, nationally, of this information should be possible as the majority of STI clinics do collect recent sexual behaviours for MSM [36] . The collection of some sexual behavioural information is currently being piloted in a small number of STI clinics with the view to expand data collection to all STI clinics in the country.
Our findings may particularly be useful to clinicians, who should consider targeting HIV prevention services to repeat testers and core subgroups within this population. Our results may also support policy makers developing guidelines for individuals eligible for pre-exposure prophylaxis (PrEP) following a recent UK trial which found PrEP to be highly effective at reducing HIV infection among MSM [37] . Men with a history of bacterial STIs, particularly syphilis, were at increased risk of subsequently acquiring HIV infection. Approximately 2500 repeat-testing MSM were diagnosed with a bacterial STI in the previous year, a number that could reasonably be enrolled in a PrEP programme that offers comprehensive HIV and STI prevention.
A large number of HIV-negative MSM annually attended STI clinics in England, with at least a third testing for HIV twice within 1 year at the same clinic. Among these repeat testers, we demonstrated a high HIV incidence and highlighted some heterogeneity in HIV risk. Using clinical history with additional behavioural data could allow more nuanced risk stratification of MSM, which in turn could better enable clinicians to direct intensified HIV prevention to higher risk MSM who are in greatest need of these services to facilitate a reduction in HIV incidence. 
